| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.4M | -3.3% | +29.6% |
| SG&A Expense | $1.7M | -11.0% | -36.7% |
| Operating Income | -$3.2M | +7.7% | +17.8% |
| Pre-tax Income | -$3.1M | +8.7% | +19.2% |
| Income Tax | $0 | -100.0% | -100.0% |
| Net Income | -$3.1M | +8.8% | +19.3% |
| EPS (Basic) | -$2.36 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.6M | -25.5% | -61.3% |
| Current Assets | $9.8M | -24.9% | -53.8% |
| Total Assets | $10.7M | -21.6% | -54.1% |
| Current Liabilities | $2.6M | -0.2% | +7.5% |
| Total Liabilities | $2.7M | -0.3% | +11.8% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.3M | — | — |
| Investing Cash Flow | $11.7M | — | — |
| +9.2% |
| +30.4% |
| EPS (Diluted) | -$2.36 | +9.2% | +30.4% |
| $8.0M |
| -26.9% |
| -61.8% |